Daymark Wealth Partners’s Globus Medical GMED Stock Holding History

Daymark Wealth Partners’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$295K	Buy	+3,932	New	+$311K	0.01%	699

Other funds holding GMED

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return

Geneva Capital Management Milwaukee, Wisconsin $3.59B AUM 12.18% 1-Year Est. Return

Daymark Wealth Partners's GMED Position: Q3 2026 in Review

Daymark Wealth Partners opened a new position in Globus Medical (GMED) in Q3 2026: 3,932 shares worth $295K. The stake represents 0.01% of the portfolio and ranks #699 among its holdings.

369 funds tracked by Wall St. Rank hold GMED as of Q3 2026.

Daymark Wealth Partners held 3,932 shares of Globus Medical worth $295K as of Q3 2026.
Globus Medical was a new Daymark Wealth Partners position in Q3 2026.
Globus Medical made up 0.01% of Daymark Wealth Partners's portfolio in Q3 2026, its #699 holding.
369 funds tracked by Wall St. Rank held Globus Medical as of Q3 2026.

Based on Daymark Wealth Partners's 13F filing for Q3 2026, filed 4 Nov 2026.